Pharmacotherapy for Pediatric Neurogenic Bladder-Reference-Cited by-同舟云学术

Pharmacotherapy for Pediatric Neurogenic Bladder

Published:2017-07-15 Issue:5 Volume:19 Page:463-478
ISSN:1174-5878
Container-title:Pediatric Drugs
language:en
Short-container-title:Pediatr Drugs

Author:

Kroll Paweł^ORCID

Publisher

Springer Science and Business Media LLC

Subject

Pharmacology (medical),Pediatrics, Perinatology and Child Health

Link

http://link.springer.com/article/10.1007/s40272-017-0249-x/fulltext.html

Reference160 articles.

1. Rackley R, Vasavada SP, Firoozi F, Ingber MS. Neurogenic bladder. eMedicine 2009. http://emedicine.medscape.com/article/453539-overview#showall . Accessed March 2017.

2. Fowler CJ, Griffiths D, de Groat WC. The neural control of micturition. Nat Rev Neurosci. 2008;9:453–66.

3. Marshall DF, Boston VE. Does bladder capacity assessment by frequency/volume chart correlate well with urodynamic estimation in children with spina bifida? Eur J Pediatr Surg. 2001;11(Suppl 1):S24–7.

4. Wen JG, Tong EC. Cystometry in infants and children with no apparent voiding symptoms. Br J Urol. 1998;81:468–73.

5. Hjälmås K. Urodynamics in normal infants and children. Scand J Urol Nephrol Suppl. 1988;114:20–7.

Cited by 20 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Comparison of the efficiency of transcutaneous electrical nerve stimulation and manual therapy in children with cerebral palsy with lower urinary system dysfunction- a randomized prospective trial;Journal of Pediatric Urology;2024-03

2. Importance of Regular Examination and Follow-up in Pediatric Patients with Neurogenic Bladder: 24-Month Follow-up Study Using a Japanese Health Insurance Database;Advances in Therapy;2023-10-16

3. Advanced Sensoring Technologies for Evaluation and Management of Lower Urinary Tract Symptoms;Advanced Sensor Research;2023-06

4. Fesoterodine treatment of pediatric patients with neurogenic detrusor overactivity: A 24-week, randomized, open-label, phase 3 study;Journal of Pediatric Urology;2023-04

5. Population Pharmacokinetic and Pharmacodynamic Modeling of Fesoterodine in Pediatric Patients with Neurogenic Detrusor Overactivity;European Journal of Drug Metabolism and Pharmacokinetics;2023-03-09